We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Top U.S. FDA Officer Details Challenges, Strides in Chinese Drug Regulation
Top U.S. FDA Officer Details Challenges, Strides in Chinese Drug Regulation
A loophole in the oversight of active pharmaceutical ingredients and an inconsistent reporting structure are just some of the challenges the U.S. Food and Drug Administration faces in improving drug quality in China, according to the agency’s top official there.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor